KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Gains from Investment Securities (2016 - 2025)

Globus Medical (GMED) has disclosed Gains from Investment Securities for 10 consecutive years, with $759000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities fell 70.72% year-over-year to $759000.0, compared with a TTM value of $759000.0 through Sep 2025, down 70.72%, and an annual FY2024 reading of $11.0 million, down 3.88% over the prior year.
  • Gains from Investment Securities was $759000.0 for Q3 2025 at Globus Medical, down from $2.3 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $59.7 million in Q3 2022 and bottomed at -$32.0 million in Q4 2022.
  • Average Gains from Investment Securities over 5 years is $9.0 million, with a median of $4.1 million recorded in 2023.
  • The sharpest move saw Gains from Investment Securities surged 10864.91% in 2021, then crashed 438.17% in 2022.
  • Year by year, Gains from Investment Securities stood at $9.5 million in 2021, then plummeted by 438.17% to -$32.0 million in 2022, then surged by 135.63% to $11.4 million in 2023, then soared by 57.12% to $17.9 million in 2024, then plummeted by 95.76% to $759000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for GMED at $759000.0 in Q3 2025, $2.3 million in Q1 2025, and $17.9 million in Q4 2024.